Roth Capital Starts IRadimed Corp (IRMD) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts IRMD Hot Sheet
Price: $87.64 --0%
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 9 | New: 12
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 9 | New: 12
Join SI Premium – FREE
Roth Capital initiated coverage on IRadimed Corp (NASDAQ: IRMD) with a Buy rating and a price target of $14.00.
For an analyst ratings summary and ratings history on IRadimed Corp click here. For more ratings news on IRadimed Corp click here.
Shares of IRadimed Corp closed at $11.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Starts VSE Corporation (VSEC) at Sector Weight
- Cantor Fitzgerald Starts Quantum Corp. (QMCO) at Overweight
- Canaccord Starts Kimberly Clark (KMB) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
